TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

by Gupta, M, Neavin, D, Liu, D, Biernacka, J, Hall-Flavin, D, Bobo, W V, Frye, M A, Skime, M, Jenkins, G D, Batzler, A, Kalari, K, Matson, W, Bhasin, S S, Zhu, H, Mushiroda, T, Nakamura, Y, Kubo, M, Wang, L, Kaddurah-Daouk, R, Weinshilboum, R M
Published 2016

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate

by Karpyak, V M, Biernacka, J M, Geske, J R, Jenkins, G D, Cunningham, J M, Rüegg, J, Kononenko, O, Leontovich, A A, Abulseoud, O A, Hall-Flavin, D K, Loukianova, L L, Schneekloth, T D, Skime, M K, Frank, J, Nöthen, M M, Rietschel, M, Kiefer, F, Mann, K F, Weinshilboum, R M, Frye, M A, Choi, D S
Published 2014

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

by Biernacka, J M, Sangkuhl, K, Jenkins, G, Whaley, R M, Barman, P, Batzler, A, Altman, R B, Arolt, V, Brockmöller, J, Chen, C H, Domschke, K, Hall-Flavin, D K, Hong, C J, Illi, A, Ji, Y, Kampman, O, Kinoshita, T, Leinonen, E, Liou, Y J, Mushiroda, T, Nonen, S, Skime, M K, Wang, L, Baune, B T, Kato, M, Liu, Y L, Praphanphoj, V, Stingl, J C, Tsai, S J, Kubo, M, Klein, T E, Weinshilboum, R
Published 2015